Hood River Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
Hood River Capital Management LLC
- $5.27 Billion
- Q1 2025
A detailed history of Hood River Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 243,994 shares of MDGL stock, worth $73.2 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
243,994
Previous 127,839
90.86%
Holding current value
$73.2 Million
Previous $39.4 Million
104.88%
% of portfolio
1.53%
Previous 0.68%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$662 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$630 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$607 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$598 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$593 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.13B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...